Cochrane Pregnancy and Childbirth has produced many reviews of interventions relevant to the organization and delivery of maternity care. In this podcast, two of the group’s researchers, Cristina Fernandez Turienzo and Hannah Rayment-Jones, midwives and senior research fellows at King’s College London in the UK, discuss their April 2024 update for one of these reviews, looking at the effects of midwife continuity of care models for childbearing women.

In its nearly 30 years, the Cochrane Schizophrenia Group produced more than 250 reviews. One of its last, published in March 2024, looked at cognitive behavioural therapy for first episode and recent-onset psychosis. Here’s lead author, Susanna Mayer from the Technical University of Munich in Germany to tell us more.

There are more than 100 Cochrane reviews relevant to dementia, and these were added to in December 2024 with a new review of the accuracy of self-administered cognitive assessment tools for its detection. In this podcast, Podcast Editor for the Cochrane Library, Mike Clarke, talks with one of the authors, Fariha Naeem from Glasgow Royal Infirmary in Scotland, about the review and its findings.

There are more than 60 Cochrane Reviews relevant to multiple sclerosis and, one of these, a network meta-analysis of immunomodulators and immunosuppressants for progressive multiple sclerosis, was updated in September 2024. We asked one of the authors, Francesco Nonino from the Istituto delle Scienze Neurologiche di Bologna in Italy, to tell us about the condition and the latest evidence in this podcast.

Helping young people develop a healthy lifestyle could have long term implications for their health and wellbeing. In this podcast, Mia Parkinson, Cochrane Communications Officer, talks with Daniel Lee from the University of Newcastle in Callaghan, Australia, about the December 2024 update of the Cochrane review of ways to enhance the implementation of school-based policies or practices to improve diet and physical activity and reduce obesity, and the use of tobacco and alcohol.

Infectious diseases are a major cause of illness and death among older adults. Vaccines can prevent some of these diseases but the uptake of vaccination among older adults varies across settings and groups. Communication with their healthcare worker can help older people makes decisions about vaccination and this is explored in the July 2021 Cochrane qualitative evidence synthesis of healthcare workers’ perceptions and experiences of communicating with people over 50 about vaccination. In this podcast, two authors of this synthesis, Simon Lewin from the Norwegian Institute of Public Health and the Norwegian University of Science and Technology, and Claire Glenton from the Western Norway University of Applied Sciences, discuss why they did the review and what they found.

The Cochrane Heart Group’s reviews cover a very wide range of topics, including several relevant to cardiac surgery. In March 2024, their review of using prophylactic corticosteroids for cardiopulmonary bypass was updated. In this podcast, Carla Lucarelli from Imperial College London speaks with new lead author, Riccardo Abbasciano from the University of Leicester in the UK about this latest version of the review.

Cochrane Reviews cover a very wide range of interventions for people with heart disease. One of these looks at exercise-based rehabilitation for patients with heart failure and it was updated for the fourth time in March 2024. Two of the authors, Rod Taylor and Cal Molloy from the University of Glasgow in the UK, discuss the latest findings in this podcast.

Cochrane Breast Cancer has produced several reviews relevant to the detection of breast cancer. In April 2023, these were added to with a new review of training health workers in low- and middle-income countries to do breast examinations. Here is the lead author, Shahin Sayed from the Aga Khan University in Nairobi Kenya, to tell us about the importance of the review and its findings.

Alongside Cochrane Reviews of the effects of original drugs for the treatment of some diseases, reviews are starting to appear of the effects of biosimilars for these drugs. In this podcast, Roses Parker, Cochrane’s Commissioning Editor tells us about the evidence in one of these reviews, published in November 2024, which considers biosimilar monoclonal antibodies for the treatment of patients with cancer.